Titan Pharmaceuticals
TTNP
#10925
Rank
NZ$10.36 M
Marketcap
NZ$7.79
Share price
-3.76%
Change (1 day)
15.74%
Change (1 year)

Earnings for Titan Pharmaceuticals (TTNP)

Earnings in 2025 (TTM): -NZ$4.73 Million

According to Titan Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$7.96 Million, an increase over its 2023 earnings that were of -NZ$9.42 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Titan Pharmaceuticals from 1995 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$4.73 Million-40.57%
2024 -NZ$7.96 Million-15.5%
2023 -NZ$9.42 Million-45.43%
2022 -NZ$17.26 Million16.29%
2021 -NZ$14.84 Million-907.36%
2020 NZ$1.83 M-106.6%
2019 -NZ$27.82 Million82.4%
2018 -NZ$15.26 Million-36.93%
2017 -NZ$24.19 Million-378.62%
2016 NZ$8.67 M-145.53%
2015 -NZ$19.07 Million369.37%
2014 -NZ$4.07 Million-125.9%
2013 NZ$15.68 M-177.74%
2012 -NZ$20.18 Million13.59%
2011 -NZ$17.76 Million74.37%
2010 -NZ$10.19 Million3.61%
2009 -NZ$9.83 Million
2007 -NZ$31.16 Million12.08%
2006 -NZ$27.81 Million-28.65%
2005 -NZ$38.97 Million-10.03%
2004 -NZ$43.31 Million-6.08%
2003 -NZ$46.11 Million-14.76%
2002 -NZ$54.1 Million32.52%
2001 -NZ$40.83 Million27.55%
2000 -NZ$32.01 Million62.5%
1999 -NZ$19.7 Million4.04%
1998 -NZ$18.94 Million49.33%
1997 -NZ$12.68 Million-27.88%
1996 -NZ$17.58 Million13.04%
1995 -NZ$15.56 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$43.91 B-926,267.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$26.67 B-562,809.45%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-NZ$0.28 Billion 5,617.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$0.13 B-2,882.64%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-NZ$19.81 Million 317.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.53 Billion 10,918.25%๐Ÿ‡บ๐Ÿ‡ธ USA